Let’s talk about something most doctors still aren’t saying clearly enough: estrogen matters for your brain. In this episode, I review what the research actually shows about HRT and long-term brain protection.
Alzheimer’s disease is the leading cause of death for women over 65 in the U.S. and Australia. And it’s not just because we live longer — women are more biologically vulnerable. One major reason? Estrogen loss.
Let's look at a 2023 comprehensive review of over 6 million women that looked at whether hormone therapy helps or harms brain health. Spoiler alert: timing matters. This episode is especially important for women in perimenopause or newly postmenopausal who are being told to “just wait it out.”
The Alzheimer’s crisis in women
Over 2/3 of Alzheimer’s cases are women
Not just about longevity — estrogen plays a direct role in brain protection
Major takeaways from the 2023 neuroscience meta-analysis
Over 6 million women studied
Combined randomized trials + real-world data
Main finding: Timing and type of hormone therapy make all the difference
When hormone therapy helps protect your brain
Estrogen started in midlife (around age 50) reduced Alzheimer’s risk by 32%
Observational studies showed a 22% lower risk of Alzheimer’s and a 19% reduced risk of all-cause dementia
Women on estrogen-only therapy had better cognitive outcomes than those on estrogen + synthetic progestins
Longer duration (>6 years) of HRT use = greater brain benefit
When it may not help — or may even increase risk
Women who start hormone therapy after age 65 or well past menopause may see no benefit or increased risk
This risk mostly applies to oral estrogen and progestins (synthetic, not bioidentical)
Think of it like sunscreen: starting after the damage has been done doesn’t help much
The “Window of Opportunity” Concept
Best brain benefits come from starting HRT during perimenopause or early postmenopause (within 10 years of last period)
Estrogen is neuroprotective during this transition — but less effective if cognitive decline has already started
Why synthetic progestins fall short
Studies consistently show better brain outcomes without progestins
We still lack data on bioidentical progesterone and brain health — more research needed
Bottom line: avoid synthetic versions if possible
If you’re already over 65 — is it too late?
Not necessarily
HRT may still help with other issues like bone, sleep, or quality of life
But brain protection may not be as significant
Requires individualized risk-benefit analysis
Every woman deserves a personalized, balanced discussion about hormone therapy — not one-size-fits-all advice based on outdated studies. If you’re in your 40s or 50s, this is the time to have that conversation — not after problems start.
Podden och tillhörande omslagsbild på den här sidan tillhör
Kristin Jackson. Innehållet i podden är skapat av Kristin Jackson och inte av,
eller tillsammans med, Poddtoppen.